On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site

Eirinaios I. Vrettos, Gábor Mező and Andreas G. Tzakos
Beilstein J. Org. Chem. 2018, 14, 930–954. https://doi.org/10.3762/bjoc.14.80

Cite the Following Article

On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
Eirinaios I. Vrettos, Gábor Mező and Andreas G. Tzakos
Beilstein J. Org. Chem. 2018, 14, 930–954. https://doi.org/10.3762/bjoc.14.80

How to Cite

Vrettos, E. I.; Mező, G.; Tzakos, A. G. Beilstein J. Org. Chem. 2018, 14, 930–954. doi:10.3762/bjoc.14.80

Download Citation

Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Zotero.

Presentation Graphic

Picture with graphical abstract, title and authors for social media postings and presentations.
Format: PNG Size: 297.5 KB Download

Citations to This Article

Up to 20 of the most recent references are displayed here.

Scholarly Works

  • Zhou, L.; Lu, Y.; Liu, W.; Wang, S.; Wang, L.; Zheng, P.; Zi, G.; Liu, H.; Liu, W.; Wei, S. Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice. Experimental hematology & oncology 2024, 13, 26. doi:10.1186/s40164-024-00493-8
  • Zhang, J.; Hu, F.; Aras, O.; Chai, Y.; An, F. Small Molecule-Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs. ChemMedChem 2024, e202300720. doi:10.1002/cmdc.202300720
  • Budka, J.; Debowski, D.; Mai, S.; Narajczyk, M.; Hac, S.; Rolka, K.; Vrettos, E. I.; Tzakos, A. G.; Inkielewicz-Stepniak, I. Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma. Pharmaceutics 2024, 16, 283. doi:10.3390/pharmaceutics16020283
  • Guo, X.-Y.; Yi, L.; Yang, J.; An, H.-W.; Yang, Z.-X.; Wang, H. Self-assembly of peptide nanomaterials at biointerfaces: molecular design and biomedical applications. Chemical communications (Cambridge, England) 2024, 60, 2009–2021. doi:10.1039/d3cc05811e
  • Wang, Y.; Zhang, L.; Liu, C.; Luo, Y.; Chen, D. Peptide-Mediated Nanocarriers for Targeted Drug Delivery: Developments and Strategies. Pharmaceutics 2024, 16, 240. doi:10.3390/pharmaceutics16020240
  • Mező, G.; Gomena, J.; Ranđelović, I.; Dókus, E. L.; Kiss, K.; Pethő, L.; Schuster, S.; Vári, B.; Vári-Mező, D.; Lajkó, E.; Polgár, L.; Kőhidai, L.; Tóvári, J.; Szabó, I. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview. International journal of molecular sciences 2024, 25, 1864. doi:10.3390/ijms25031864
  • Rizvi, S. F. A.; Zhang, L.; Zhang, H.; Fang, Q. Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic. ACS pharmacology & translational science 2024, 7, 309–334. doi:10.1021/acsptsci.3c00269
  • Zeng, W.; Xue, J.; Geng, H.; Liu, X.; Yang, J.; Shen, W.; Yuan, Y.; Qiang, Y.; Zhu, Q. Research progress on chemical modifications of tyrosine residues in peptides and proteins. Biotechnology and bioengineering 2023, 121, 799–822. doi:10.1002/bit.28622
  • Ahmed, Y. W.; Tsai, H.-C.; Wu, T.-Y.; Darge, H. F.; Chen, Y.-S. Role of thermal and reactive oxygen species-responsive synthetic hydrogels in localized cancer treatment (bibliometric analysis and review). Materials Advances 2023, 4, 6118–6151. doi:10.1039/d3ma00341h
  • Sviben, I.; Glavaš, M.; Erben, A.; Bachelart, T.; Pavlović Saftić, D.; Piantanida, I.; Basarić, N. Dipeptides Containing Pyrene and Modified Photochemically Reactive Tyrosine: Noncovalent and Covalent Binding to Polynucleotides. Molecules (Basel, Switzerland) 2023, 28, 7533. doi:10.3390/molecules28227533
  • Koutsopetras, I.; Mishra, A. K.; Benazza, R.; Hernandez-Alba, O.; Cianférani, S.; Chaubet, G.; Nicolai, S.; Waser, J. Cysteine-Cysteine Cross-Conjugation of both Peptides and Proteins with a Bifunctional Hypervalent Iodine-Electrophilic Reagent. Chemistry (Weinheim an der Bergstrasse, Germany) 2023, 29, e202302689. doi:10.1002/chem.202302689
  • Biniari, G.; Markatos, C.; Nteli, A.; Tzoupis, H.; Simal, C.; Vlamis-Gardikas, A.; Karageorgos, V.; Pirmettis, I.; Petrou, P.; Venihaki, M.; Liapakis, G.; Tselios, T. Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer. International journal of molecular sciences 2023, 24, 15232. doi:10.3390/ijms242015232
  • Jalil, A. T.; Abdulhadi, M. A.; Al-Ameer, L. R.; Taher, W. M.; Abdulameer, S. J.; Abosaooda, M.; Fadhil, A. A. Peptide-Based Therapeutics in Cancer Therapy. Molecular biotechnology 2023. doi:10.1007/s12033-023-00873-1
  • Xu, J.; Song, M.; Fang, Z.; Zheng, L.; Wang, J.; Liu, K. A chemoimmunotherapy-based strategy to enhance tumor therapy by cross-linking a novel size-variable nanocluster via a bifunctional peptide. Materials & Design 2023, 233, 112232. doi:10.1016/j.matdes.2023.112232
  • Ma, H.; Pan, Z.; Lai, B.; Zan, C.; Liu, H. Recent Research Advances in Nano-Based Drug Delivery Systems for Local Anesthetics. Drug design, development and therapy 2023, 17, 2639–2655. doi:10.2147/dddt.s417051
  • Tan, X.; Le, M.; Wang, H.; Huo, B.; Yu, T.; Huang, P.; Luan, T.; Wen, S. Design and synthesis of peptide-drug conjugates to double target EGFR. Phytochemistry Letters 2023, 56, 30–37. doi:10.1016/j.phytol.2023.06.003
  • Ogundipe, O. D.; Olajubutu, O.; Adesina, S. K. Targeted drug conjugate systems for ovarian cancer chemotherapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023, 165, 115151. doi:10.1016/j.biopha.2023.115151
  • Davis, R. A.; Ganguly, T.; Harris, R.; Hausner, S. H.; Kovacs, L.; Sutcliffe, J. L. Synthesis and Evaluation of a Monomethyl Auristatin E─Integrin αvβ6 Binding Peptide-Drug Conjugate for Tumor Targeted Drug Delivery. Journal of medicinal chemistry 2023, 66, 9842–9852. doi:10.1021/acs.jmedchem.3c00631
  • Ziaei, E.; Paiva, I. M. d.; Yao, S.-J.; Sarrami, N.; Mehinrad, P.; Lai, J.; Lavasanifar, A.; Kaur, K. Peptide-Drug Conjugate Targeting Keratin 1 Inhibits Triple-Negative Breast Cancer in Mice. Molecular pharmaceutics 2023, 20, 3570–3577. doi:10.1021/acs.molpharmaceut.3c00189
  • Puc Encalada, I.; Carrillo Cocom, L. M.; Quintal Bojórquez, N. d. C.; Segura Campos, M. R. Bibliometric Analysis of the Role of Bioactive Peptides in Cancer Therapy. International Journal of Peptide Research and Therapeutics 2023, 29. doi:10.1007/s10989-023-10538-x


  • MARSHALL DANIEL RICHARD; CSENGERY JOHANNA MARIE; MAGUIRE ROBERT JOHN; VOLKMANN ROBERT A. Peptide conjugates of cytotoxins as therapeutics. US 11634508 B2, April 25, 2023.
Other Beilstein-Institut Open Science Activities